A Multicenter, Real‐world Study on Effectiveness and Safety of First‐line Modified PD‐1 Inhibitors with Chemotherapy in Advanced Non‐small Cell Lung Cancer (ansclc) with Drive Gene‐negative
CANCER MEDICINE（2024）
Key words
immunotherapy,modified PD-1 inhibitors,NSCLC,PD-1 inhibitors,Pembrolizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined